4925 — Haba Laboratories Balance Sheet
0.000.00%
- ¥7bn
- ¥5bn
- ¥12bn
- 85
- 37
- 39
- 56
Annual balance sheet for Haba Laboratories, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 5,228 | 5,664 | 5,651 | 4,818 | 3,959 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,423 | 1,200 | 1,126 | 975 | 1,258 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 11,148 | 11,314 | 10,072 | 9,344 | 9,077 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4,711 | 5,003 | 4,655 | 4,452 | 2,956 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 17,091 | 17,441 | 15,685 | 14,655 | 12,431 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3,398 | 3,453 | 2,532 | 2,798 | 2,814 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 5,119 | 5,402 | 4,048 | 3,882 | 3,924 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 11,973 | 12,039 | 11,638 | 10,774 | 8,507 |
Total Liabilities & Shareholders' Equity | 17,091 | 17,441 | 15,685 | 14,655 | 12,431 |
Total Common Shares Outstanding |